Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala

Behavioural Brain Research

Volumn 280, Issue , 2015, Pages 36-44

  Mohammadi, Meisam ^a   Nasehi, Mohammad ^b   Zarrindast, Mohammad Reza ^a,c,d,e  

^a INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

Amygdala; CB1 cannabinoid receptor; Dopamine D1 receptor; Spatial memory

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID RECEPTOR AGONIST; DOPAMINE 1 RECEPTOR; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MICROINJECTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN FUNCTION; SPATIAL MEMORY; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; INDWELLING CATHETER; MEMORY; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RANDOMIZATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ARACHIDONIC ACIDS; BASOLATERAL NUCLEAR COMPLEX; BENZAZEPINES; CANNABINOID RECEPTOR AGONISTS; CATHETERS, INDWELLING; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMORY; MICE; MOTOR ACTIVITY; RANDOM ALLOCATION; RECEPTORS, DOPAMINE D1;

EID: 84917690512     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.11.003     Document Type: Article

References (69)

1. Burgdorf J., Zhang X.L., Weiss C., Matthews E., Disterhoft J.F., Stanton P.K., et al. The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats. Neurobiol Aging 2011, 32:698-706.
2. Kilmer B., Caulkins J., Pacula R., Reuter P. Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market. Drug Alcohol Depend 2011, 119:153-160.
3. King J.A., Burgess N., Hartley T., Vargha-Khadem F., O'Keefe J. Human hippocampus and viewpoint dependence in spatial memory. Hippocampus 2002, 12:811-820.
4. Wise L.E., Thorpe A.J., Lichtman A.H. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 2009, 34:2072-2080.
5. Wiley J.L., Selley D.E., Wang P., Kottani R., Gadthula S., Mahadeven A. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB(1)) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB(1), non-CB(2) mechanism. J Pharmacol Exp Ther 2012, 340:433-444.
6. Herkenham M., Groen B.G., Lynn A.B., De Costa B.R., Richfield E.K. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res 1991, 552:301-310.
7. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
8. Avdesh A., Hoe Y., Martins R.N., Martin-Iverson M.T. Pharmacological effects of cannabinoids on the reference and working memory functions in mice. Psychopharmacology 2013, 225:483-494.
9. Wise L.E., Iredale P.A., Lichtman A.H. The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. Eur J Pharmacol 2008, 590:246-249.
10. Zarrindast M.R., Navaeian M., Nasehi M. Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neurosci Res 2011, 69:51-59.
11. Oleson E.B., Cheer J.F. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med 2012, 2:2012.
12. Phelps E.A., Delgado M.R., Nearing K.I., LeDoux J.E. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004, 43:897-905.
13. Fried I., Wilson C.L., Morrow J.W., Cameron K.A., Behnke E.D., Ackerson L.C., et al. Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat Neurosci 2001, 4:201-206.
14. Sah P., Lopez De Armentia M. Excitatory synaptic transmission in the lateral and central amygdala. Ann N Y Acad Sci 2003, 985:67-77.
15. Pare D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
16. Kelley A.E., Domesick V.B., Nauta W.J. The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience 1982, 7:615-630.
17. LaLumiere R.T., Buen T.V., McGaugh J.L. Post-training intra-basolateral amygdala infusions of norepinephrine enhance consolidation of memory for contextual fear conditioning. J Neurosci 2003, 23:6754-6758.
18. Lalumiere R.T., Nguyen L.T., McGaugh J.L. Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems. Eur J Neurosci 2004, 20:2804-2810.
19. Power A.E., McIntyre C.K., Litmanovich A., McGaugh J.L. Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. Behav Pharmacol 2003, 14:207-213.
20. Kodama T., Hikosaka K., Honda Y., Kojima T., Watanabe M. Higher dopamine release induced by less rather than more preferred reward during a working memory task in the primate prefrontal cortex. Behav Brain Res 2014, 266:104-107.
21. Nasehi M., Piri M., Nouri M., Farzin D., Nayer-Nouri T., Zarrindast M.R. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol 2010, 634:77-83.
22. Thomas M.J., Malenka R.C., Bonci A. Modulation of long-term depression by dopamine in the mesolimbic system. J Neurosci 2000, 20:5581-5586.
23. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 1991, 564:203-219.
24. Scibilia R.J., Lachowicz J.E., Kilts C.D. Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 1992, 11:146-154.
25. de la Mora M.P., Gallegos-Cari A., Arizmendi-Garcia Y., Marcellino D., Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol 2010, 90:198-216.
26. Roullet P., Mele A., Ammassari-Teule M. Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change. Psychopharmacology 1996, 126:55-61.
27. Yousefi B., Farjad M., Nasehi M., Zarrindast M.R. Involvement of the CA1 GABAA receptors in ACPA-induced impairment of spatial and non-spatial novelty detection in mice. Neurobiol Learn Mem 2013, 100:32-40.
28. Adriani W., Sargolini F., Coccurello R., Oliverio A., Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology 2000, 150:67-76.
29. Chegini H.R., Nasehi M., Zarrindast M.R. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice. Behav Brain Res 2014, 261:114-126.
30. Nasehi M., Amin Yavari S., Zarrindast M.R. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology 2013, 227:553-566.
31. Piri M., Rostampour M., Nasehi M., Zarrindast M.R. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats. Neuroscience 2013, 252:460-467.
32. Farahmandfar M., Kadivar M., Naghdi N., Choopani S., Zarrindast M.R. Influence of pre-exposure to morphine on cannabinoid-induced impairment of spatial memory in male rats. Behav Brain Res 2013, 256:157-164.
33. Jamali-Raeufy N., Nasehi M., Zarrindast M.R. Influence of N-methyl d-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behav Pharmacol 2011, 22:645-654.
34. Sun N., Laviolette S.R. Inactivation of the basolateral amygdala during opiate reward learning disinhibits prelimbic cortical neurons and modulates associative memory extinction. Psychopharmacology 2012, 222:645-661.
35. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 2002, 42:993-1007.
36. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Ann Rev Physiol 2009, 71:283-306.
37. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 1998, 51:391-402.
38. Hoffman A.F., Riegel A.C., Lupica C.R. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. Eur J Neurosci 2003, 18:524-534.
39. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999, 19:4544-4558.
40. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999, 11:4213-4225.
41. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
42. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce. Nat Rev Drug Discov 2008, 7:438-455.
43. Yim T.T., Hong N.S., Ejaredar M., McKenna J.E., McDonald R.J. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience 2008, 151:929-936.
44. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:321-325.
45. Takahashi R.N., Pamplona F.A., Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 2005, 380:270-275.
46. Robinson L., McKillop-Smith S., Ross N.L., Pertwee R.G., Hampson R.E., Platt B., et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology 2008, 198:551-563.
47. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 2009, 92:391-399.
48. Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci 2011, 5:34.
49. Brusco A., Tagliaferro P.A., Saez T., Onaivi E.S. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 2008, 1139:450-457.
50. Mackie K., Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 2006, 8:E298-E306.
51. Goddard G.V. Functions of the amygdala. Psychol Bull 1964, 62:89-109.
52. Tan H., Lauzon N.M., Bishop S.F., Chi N., Bechard M., Laviolette S.R. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci 2011, 31:5300-5312.
53. McGaugh J.L., McIntyre C.K., Power A.E. Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol Learn Mem 2002, 78:539-552.
54. Goosens K.A., Maren S. NMDA receptors are essential for the acquisition, but not expression, of conditional fear and associative spike firing in the lateral amygdala. Eur J Neurosci 2004, 20:537-548.
55. Kim J.J., Lee H.J., Han J.S., Packard M.G. Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci 2001, 21:5222-5228.
56. Cahill L. Neurobiological mechanisms of emotionally influenced, long-term memory. Prog Brain Res 2000, 126:29-37.
57. Canli T., Zhao Z., Brewer J., Gabrieli J.D., Cahill L. Event-related activation in the human amygdala associates with later memory for individual emotional experience. J Neurosci 2000, 20:RC99.
58. Asan E. The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 1998, 142:1-118.
59. Ito M., Numachi Y., Ohara A., Sora I. Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors. Neurosci Lett 2008, 438:327-329.
60. Rosenkranz J.A., Grace A.A. Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning. Nature 2002, 417:282-287.
61. Fuxe K., Jacobsen K.X., Hoistad M., Tinner B., Jansson A., Staines W.A., et al. The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation. Neuroscience 2003, 119:733-746.
62. Palomares-Castillo E., Hernandez-Perez O.R., Perez-Carrera D., Crespo-Ramirez M., Fuxe K., Perez de la Mora M. The intercalated paracapsular islands as a module for integration of signals regulating anxiety in the amygdala. Brain Res 2012, 1476:211-234.
63. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315-348.
64. Molina-Holgado F., Amaro A., Gonzalez M.I., Alvarez F.J., Leret M.L. Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system. Eur J Pharmacol 1996, 316:39-42.
65. Foldy C., Neu A., Jones M.V., Soltesz I. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 2006, 26:1465-1469.
66. Laviolette S.R., Grace A.A. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 2006, 63:1597-1613.
67. Millan M.J., Newman-Tancredi A., Quentric Y., Cussac D. The selective dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin 2C receptors. Psychopharmacology 2001, 156:58-62.
68. Zarrindast M.R., Honardar Z., Sanea F., Owji A.A. SKF 38393 and SCH 23390 inhibit reuptake of serotonin by rat hypothalamic synaptosomes. Pharmacology 2011, 87:85-89.
69. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press. 2nd Ed.